pharmacogenomics
The three-year Ubiquitous Pharmacogenomics Consortium's PREPARE study enrolled nearly 7,000 patients in seven European countries.
Doctors will be able to test patients for 17 genes known to influence response to 62 drugs and receive guidance from EHR-embedded pre- and post-test alerts.
In the Instand-NGS4P program, a group of seven European hospitals are encouraging technology vendors to innovate by offering a path to IVDR compliance and a wide market for new products.
NewStem, MSK Innovation Hub Team to Validate Cancer Diagnostics Software Platform
The Israeli startup called this collaboration a necessary step toward commercializing its CE-marked NewStem Software Diagnostic Device for reducing oncology drug resistance.
The All of Us Research Program began releasing ancestry and other nonclinical genetic results to participants in 2020 but will now return disease risk and PGx reports.